Journal of Pediatric Hematology/Oncology · 2013 · 29 citations · 18 references
MedicinePharmacokineticsPharmacologyDrug MetabolismMedical GeneticsPharmacogeneticsCytochrome P450 EnzymesCytochrome P450-mediated MetabolismDrug Metabolism GeneticsDrug Metabolism GenomicsPharmacogenetic TestingPharmacogenomics In ChildrenAnalgesic EffectsCyp2d6 Drug MetabolismCyp2d6 GenotypeCyp2d6 GenotypingCytochrome P450 2D6Cytochrome P450 Genetic PolymorphismMetabolic Conversion PathwaysOpioid Metabolism
The opioid medications codeine and hydrocodone, commonly prescribed in sickle cell disease (SCD), require metabolic conversion by cytochrome P450 2D6 (CYP2D6) to morphine and hydromorphone, respectively, to exert their analgesic effects. The CYP2D6 gene is highly polymorphic, with variant alleles that result in decreased, absent, or ultrarapid enzyme activity. Seventy-five children with SCD were tested for CYP2D6 polymorphisms, and metabolic phenotypes were inferred from the genotypes. The most common variant alleles were CYP2D6*2 (normal activity, 28.7%), CYP2D6*17 (reduced activity, 17.3%), CYP2D6*5 (gene deletion, 8.7%), and CYP2D6*4 (absent function, 8.0%). Normal/extensive metabolizer genotypes were found in 28/75 (37.5%), intermediate metabolism in 33/75 (44.0%), poor metabolism in 4/75 (5.3%), ultrarapid metabolism in 3/75 (4.0%), indeterminate in 6/75 (8.0%). Allele frequencies did not vary significantly among different hemoglobin genotypes. Identification of variant CYP2D6 genotypes may identify individuals with altered metabolism and therefore altered analgesic response to codeine and hydrocodone, thus providing a personalized medicine approach to treatment of pain in SCD. Further pharmacokinetic and pharmacodynamic studies are needed to define the relationship of CYP2D6 and other gene polymorphisms to individual opioid effect in SCD.
18
Codeine Intoxication Associated with Ultrarapid CYP2D6 Metabolism
Yvan Gasche, Youssef Daali, Marc Fathi et al. · New England Journal of Medicine · 2004 · 700 citations · Full text
Medicine, Pharmacology, Toxicology +17
Nomenclature for human CYP2D6 alleles
Ann K. Daly, Jürgen Brockmöller, Franck Broly et al. · Pharmacogenetics · 1996 · 400 citations
Kristine R. Crews, Andrea Gaedigk, Henry M. Dunnenberger et al. · Clinical Pharmacology & Therapeutics · 2011 · 368 citations · Full text